# Rosmarinic Acid Cognition Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/rosmarinic-acid-cognition-meta-analysis-evidence-review
Category: evidence-review
Summary: Rosmarinic Acid Cognition Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are
Last reviewed: 2026-08-19
Reviewed by: Migaku Evidence Review
# Rosmarinic Acid Cognition Meta-analysis: What the Evidence Says

## Quick Answer

Rosmarinic Acid Cognition Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 narrative review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Advances in Bioactive Compounds from Plants and Their Applications in Alzheimer&#8217;s Disease | narrative review | 3 | 2025-12-19 | 10.3390/biom16010007 |
| Unraveling the Effects of Melissa officinalis L. on Cognition and Sleep Quality: A Narrative Review | preclinical study | 4 | 2025-10-30 | 10.3390/ijms262110566 |

## What The Sources Report

- The combination of advancing age with genetic predisposition, and lifestyle choices determines an individual's risk level. [Pavlov Steve (2025); evidence level 3]
- The ApoE &#949;4 allele stands as the leading genetic risk factor for late-onset AD, but rare autosomal-dominant mutations in amyloid precursor protein (APP) and PSEN1 and PSEN2 genes cause early-onset familial AD. [Pavlov Steve (2025); evidence level 3]
- According to the World Health Organization (WHO), aging is a process that involves biological, psychological, and social changes, which can lead to increased vulnerability to disease and a greater need for healthcare. [Oliveira Maria Vit&#243;ria Barroso (2025); evidence level 4]
- As a result, some projections indicate that by 2050, one in six people worldwide will be 65 years of age or older. [Oliveira Maria Vit&#243;ria Barroso (2025); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For rosmarinic acid cognition meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Pavlov Steve (2025). Advances in Bioactive Compounds from Plants and Their Applications in Alzheimer&#8217;s Disease. DOI: 10.3390/biom16010007. PMCID: PMC12839116. PMID: 41594549. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12839116/
- Oliveira Maria Vit&#243;ria Barroso (2025). Unraveling the Effects of Melissa officinalis L. on Cognition and Sleep Quality: A Narrative Review. DOI: 10.3390/ijms262110566. PMCID: PMC12610505. PMID: 41226605. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12610505/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.